Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sildenafil for Endothelial Function in Type 2 Diabetes
NCT00420901Phase 3Completed
- Sponsor
- IRCCS Ospedale San Raffaele
- Start
- Jan 1999
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of sildenafil in type 2 diabetes mellitus (T2DM), sponsored by IRCCS Ospedale San Raffaele. Started Jan 1999; status: completed.
02
Drugs
sildenafil
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00420901.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00420901.